Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria

por Hamaoka, T, Costelloe, C M, Madewell, J E, Liu, P, Hortobagyi, G N, Ueno, N T
Publicado 2010

Multiple Myeloma: A Review of Imaging Features and Radiological Techniques

por Healy, C. F., Murray, J. G., Eustace, S. J., Madewell, J., O'Gorman, P. J., O'Sullivan, P.
Publicado 2011

Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

por Hamaoka, T, Costelloe, C M, Madewell, J E, Liu, P, Berry, D A, Islam, R, Theriault, R L, Hortobagyi, G N, Ueno, N T
Publicado 2010

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard

por Livingston, J. A., Bugano, D., Barbo, A., Lin, H., Madewell, J. E., Wang, W. L., Lazar, A. J., Tseng, W. W., Roland, C. L., Feig, B. W., Pollock, R., Conley, A. P., Benjamin, R. S., Patel, S., Somaiah, N.
Publicado 2017

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI

por Guo, J, Glass, J O, McCarville, M B, Shulkin, B L, Daryani, V M, Stewart, C F, Wu, J, Mao, S, Dwek, J R, Fayad, L M, Madewell, J E, Navid, F, Daw, N C, Reddick, W E
Publicado 2015